doi:10.3945/an.110.1008 [5] Elkin RG, Featherston WR, Rogler JC
98-4321-R14-3/98 PRINCIPAL DISPLAY PANEL - 2 g/50 mL Bag Label 50 mL NDC 0409-6729-11 MAGNESIUM SULFATE IN WATER FOR INJECTION 2g TOTAL 2 g/50 mL (40 mg/mL) EACH 50 mL CONTAINS MAGNESIUM SULFATE HEPTAHYDRATE 2 g (EQUIVALENT TO 16.25 mEq MAGNESIUM) IN WATER FOR INJECTION
Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia
A 2020 preclinical toxicity review found no serious toxicity in mice, rats, rabbits, or dogs at tested doses, but longterm human carcinogenicity or organtoxicity data are missing
Now, before I lose you, let me hook you with this graph: In a double-blind, placebo-controlled 26-week study, patients given tesamorelin saw about a 15% reduction in visceral fat, while the placebo group actually trended upward (A)
Combined fludarabine, cyclophosphamide, and rituximab achieves a high complete remission rate as initial treatment for chronic lymphocytic leukemia